Literature DB >> 26566429

Optimization of the generator settings for endobiliary radiofrequency ablation.

Maximilien Barret1, Sarah Leblanc1, Ariane Vienne1, Alexandre Rouquette1, Frederic Beuvon1, Stanislas Chaussade1, Frederic Prat1.   

Abstract

AIM: To determine the optimal generator settings for endobiliary radiofrequency ablation.
METHODS: Endobiliary radiofrequency ablation was performed in live swine on the ampulla of Vater, the common bile duct and in the hepatic parenchyma. Radiofrequency ablation time, "effect", and power were allowed to vary. The animals were sacrificed two hours after the procedure. Histopathological assessment of the depth of the thermal lesions was performed.
RESULTS: Twenty-five radiofrequency bursts were applied in three swine. In the ampulla of Vater (n = 3), necrosis of the duodenal wall was observed starting with an effect set at 8, power output set at 10 W, and a 30 s shot duration, whereas superficial mucosal damage of up to 350 μm in depth was recorded for an effect set at 8, power output set at 6 W and a 30 s shot duration. In the common bile duct (n = 4), a 1070 μm, safe and efficient ablation was obtained for an effect set at 8, a power output of 8 W, and an ablation time of 30 s. Within the hepatic parenchyma (n = 18), the depth of tissue damage varied from 1620 μm (effect = 8, power = 10 W, ablation time = 15 s) to 4480 μm (effect = 8, power = 8 W, ablation time = 90 s).
CONCLUSION: The duration of the catheter application appeared to be the most important parameter influencing the depth of the thermal injury during endobiliary radiofrequency ablation. In healthy swine, the currently recommended settings of the generator may induce severe, supratherapeutic tissue damage in the biliary tree, especially in the high-risk area of the ampulla of Vater.

Entities:  

Keywords:  Ampullary tumor; Biliary stricture; Endobiliary radiofrequency ablation; Endoscopic retrograde cholangio-pancreatography

Year:  2015        PMID: 26566429      PMCID: PMC4639744          DOI: 10.4253/wjge.v7.i16.1222

Source DB:  PubMed          Journal:  World J Gastrointest Endosc


  14 in total

1.  Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex-vivo pig liver.

Authors:  Takao Itoi; Hiroyuki Isayama; Atsushi Sofuni; Fumihide Itokawa; Miho Tamura; Yusuke Watanabe; Fuminori Moriyasu; Michel Kahaleh; Nagy Habib; Toshitaka Nagao; Tomohisa Yokoyama; Kazuhiko Kasuya; Hiroshi Kawakami
Journal:  J Hepatobiliary Pancreat Sci       Date:  2012-09       Impact factor: 7.027

2.  Endoscopic radiofrequency ablation of cholangiocarcinoma: new palliative treatment modality (with videos).

Authors:  Amitabh Monga; Rajesh Gupta; Mohan Ramchandani; Guduru V Rao; Darisetty Santosh; D Nageshwar Reddy
Journal:  Gastrointest Endosc       Date:  2010-12-18       Impact factor: 9.427

3.  Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction.

Authors:  Alan W Steel; Aymer J Postgate; Shirin Khorsandi; Joanna Nicholls; Long Jiao; Pangiotis Vlavianos; Nagy Habib; David Westaby
Journal:  Gastrointest Endosc       Date:  2011-01       Impact factor: 9.427

4.  Intraductal radiofrequency ablation for refractory benign biliary stricture: pilot feasibility study.

Authors:  Bing Hu; Dao-Jian Gao; Jun Wu; Tian-Tian Wang; Xiao-Ming Yang; Xin Ye
Journal:  Dig Endosc       Date:  2014-01-09       Impact factor: 7.559

5.  Habib EndoHPB: a novel endobiliary radiofrequency ablation device. An experimental study.

Authors:  Dimitris Zacharoulis; Olga Lazoura; Eleni Sioka; Spyros Potamianos; George Tzovaras; Joanna Nicholls; George Koukoulis; Nagy Habib
Journal:  J Invest Surg       Date:  2012-12-28       Impact factor: 2.533

Review 6.  Endoscopic radiofrequency ablation for cholangiocarcinoma.

Authors:  Christopher A Wadsworth; David Westaby; Shahid A Khan
Journal:  Curr Opin Gastroenterol       Date:  2013-05       Impact factor: 3.287

7.  Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results.

Authors:  Malkhaz Mizandari; Madhava Pai; Feng Xi; Vlastimil Valek; Andrasina Tomas; Pietro Quaretti; Rita Golfieri; Cristina Mosconi; Ao Guokun; Charis Kyriakides; Robert Dickinson; Joanna Nicholls; Nagy Habib
Journal:  Cardiovasc Intervent Radiol       Date:  2012-12-12       Impact factor: 2.740

8.  Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications.

Authors:  Werner Dolak; Florian Schreiber; Hubert Schwaighofer; Michael Gschwantler; Wolfgang Plieschnegger; Alexander Ziachehabi; Andreas Mayer; Ludwig Kramer; Andreas Kopecky; Christiane Schrutka-Kölbl; Gernot Wolkersdörfer; Christian Madl; Frieder Berr; Michael Trauner; Andreas Püspök
Journal:  Surg Endosc       Date:  2013-10-03       Impact factor: 4.584

9.  Endobiliary radiofrequency ablation for malignant biliary obstruction.

Authors:  Halil Alis; Cetin Sengoz; Murat Gonenc; Mustafa Uygar Kalayci; Ali Kocatas
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2013-08

10.  Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique.

Authors:  Paola Figueroa-Barojas; Mihir R Bakhru; Nagy A Habib; Kristi Ellen; Jennifer Millman; Armeen Jamal-Kabani; Monica Gaidhane; Michel Kahaleh
Journal:  J Oncol       Date:  2013-04-08       Impact factor: 4.375

View more
  1 in total

1.  Intraductal temperature-controlled radiofrequency ablation in malignant hilar obstruction: a preliminary study in animals and initial human experience.

Authors:  Eui Joo Kim; Jae Hee Cho; Yoon Jae Kim; Tae Hoon Lee; Joon Mee Kim; Seok Jeong; Yeon Suk Kim
Journal:  Endosc Int Open       Date:  2019-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.